Early blood pressure level as a mark of familial aggregation of metabolic cardiovascular risk factors - The Rio de Janeiro Study

Journal of Hypertension

Volumn 16, Issue 12 SUPPL., 1998, Pages 1885-1889

  Magalhães, Maria E C ^b   Pozzan, Roberto ^b   Brandão, Andréa A ^a   Cerqueira, Rita C O ^b   Rousoulieres, Ana L S ^b   Szwarcwald, Celia ^b   Brandão, Ayrton P ^b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE

Author keywords

Blood pressure; Dyslipidemia; Familiar aggregation; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; BODY MASS; BODY WEIGHT; BRAZIL; CARDIOVASCULAR RISK; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FEMALE; HEART RATE; HEREDITY; HUMAN; HUMAN EXPERIMENT; LONGITUDINAL STUDY; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; PARENT; PRIORITY JOURNAL; SIBLING; SYSTOLIC BLOOD PRESSURE;

EID: 0345130046     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816121-00006     Document Type: Conference Paper

References (22)

1. Aitman TJ, Gotoda T, Evans AL, Imrie H, Heath KE, Trembling PM et al. Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats, Nat Genet 1997; 16:197-201.
2. Kesaniemi YA, Lilja M, Kervinem K, Rantala A, Multiple metabolic syndrome: aspects of genetic epidemiology and molecular genetics. Ann Med 1992; 24:461-464.
3. Williams RR, Hopkins PN, Hunt SC, Schumacher MC, Elbein SC, Wilson DE, et al. Familial dyslipidaemic hypertension and other multiple metabolic syndromes. Ann Med 1992; 24:469-475.
4. Williams RR, Hunt SC, Hopkins PN, Wu LL, Hasstedt SJ, Berry TD, et al. Genetic basis of dyslipidaemia and hypertension: 15-year results from Utah. Am J Hypertens 1993; 6(11 pt 2):319S-327S.
5. Weber M, McNicoll S, Marcil M, Connely P, Lussier-Cacan S, Davignon J, et al. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French-Canadians. Can J Cardiol 1997; 13:253-260.
6. Srinivasan SR, Ehnholm C, Wattigney WA, Bao W, Berenson GS. The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: the Bogalusa Heart Study. Atherosclerosis 1996; 123:33-42.
7. Caufield M, Bouloux PM, Minroe P. Progress in determining the genes for hypertension, insulin resistance and dyslipidemia. Ann NY Acad Sci 1997; 20:110-117.
8. Dubois M, Dubois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17:868-876.
9. Daniel WW. A foundation for analyses in the health sciences. In Biostatistics. Singapore: John Wiley; 1991.
10. Daniels SD, Meyer RA, Loggie JMH. Determinants of cardiac involvement in children and adolescents with hypertension. Circulation 1990; 82:1243-1248.
11. Frolish ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V et al. The heart in hypertension. N Engl J Med 1992; 327:998-1008.
12. Wattigney WA, Weber LS, Srinivasan SR, Berenson GS. The emergence of clinically abnormal levels of cardiovascular disease risk factor variables among young adults: the Bogalusa Heart Study. Prev Med 1995; 24:617-626.
13. Brandão AP, Brandão AA, Araujo EMM. The significance of physical development on blood pressure curve of children between six and nine years of age and its relationship with familial aggregation. J Hypertens 1989; 7(suppl 1):S37-S39.
14. Morris BJ. Identification of essential hypertension genes. J Hypertens 1993; 11:115-120
15. Samaras K, Campbell LV. The non-genetic determinants of central adiposity. Int J Obes Relat Metab Disord 1997; 21:839-845.
16. Vijayaraghavan S, Hitman GA, Kopelman PG. Apolipoprotein D polymorphism: a genetic marker for obesity and hyperinsulunemia. J Clin Endocrinol Metab 1994; 79:568-570.
17. Freedman DS, Shear CL, Srinivasan SR, Webber LS, Berenson GS. Tracking of serum lipids and lipoproteins in children over an eight-year period: the Bogalusa Heart Study. Prev Med 1985; 14: 203-216.
18. Schuster H, Phenotyping and genotyping patients with cardiovascular risk factors. Diabet med 1997; 14(suppl 3):S57-S59.
19. Rice T, Nadeau A, Peruse L, Bouchard C, Rao DC. Familial correlations in the Quebec family study: cross-trait familial resemblance for body fat with plasma glucose and insulin. Diabetologia 1996, 39:1357-1364.
20. Wilson PW, Myers RH, Larson MG, Ordovas JM, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia and coronary heart disease. The Framingham Offspring Study. J Am Med Assoc 1994; 272:1666-1671.
21. Current status of blood cholesterol measurements in clinical laboratories in the United States: a report from the Laboratory Standardization Panel of the National Cholesterol Education Program. Betheseda, MD: National Institutes of Health, 1998. NIH publication no. 88.
22. Hulley SB, Newman TB, Grady D, Garber AM, Baron RB Browner WS et al. Should we be measuring blood cholesterol levels in young adults? J Am Med Assoc 1993; 269:1416-1419.